Phase I Trial of DAR-901

计划入组 59 人 · 首次发布于 2014 年 2 月 14 日

A Phase 2 Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain

计划入组 209 人 · 首次发布于 2025 年 3 月 25 日

Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors

计划入组 20 人 · 首次发布于 2022 年 5 月 19 日

ST-501

ST-301

ST-201

St. Josef- und St. Elisabeth-Hospital gGmbH

Germany

St. George Hospital

Australia

ST. CATHERINE UNIVERSITY

United States

Syremis Therapeutics Launches with $165M Series A to Advance Novel Mental Health Therapies

InMed's INM-901 Shows Significant Anti-Inflammatory Activity in Alzheimer's Disease Preclinical Study

InMed's Alzheimer's Drug Candidate INM-901 Shows Favorable Bioavailability in Large Animal Studies